Glad to see the first ten medications chosen for price controls are those used by large numbers of patients and patients typically on multiple different medications concurrently (particularly diabetics), rather than a few extremely expensive but rarely used drugs.
https://www.npr.org/2023/08/29/1195984752/medicare-drug-price-negotiations
@EileenKCarpenter Several of those are drugs that appear to have dubious benefits, while the patient is on older dugs actually keeping them alive.
For instance, Jenuvia is on the list, but not insulin. Jenuvia won't keep your limbs from falling off and your organs failing without insulin, and insulin can do those things without Jenuvia. Also, Jenuvia can make your taint rot off.
This is pretending to help, while making it more dangerous not to have insurance.
It's a pattern with him.
@AskTheDevil
You're conflating type 1 and type 2 diabetes.
Type 1 absolutely must have insulin. They don't have enough.
Type 2 diabetics actually have high levels of insulin in many cases, but they are resistant to it. Using oral agents that don't increase insulin further can avoid the weight gain that insulin causes. Some have data that they reduce complications like heart attacks (eg, jardiance).
@AskTheDevil
But yeah, insulins are grossly overpriced, and type 1 diabetics are at highest risk of immediate death without it. It would be nice to see more insulins on that list.